Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: The SEPSIS-ACT randomized clinical trial

Laterre PF, Berry SM, Blemings A, et al. JAMA. 2019; 322:1476-1485.
      Septic shock is a life-threatening condition requiring the use of medications for blood pressure support. The first-line medication norepinephrine is often insufficient in restoring adequate blood pressure. Vasopressin is often used as an adjunct for blood pressure support, but each of these medications has adverse effects. Therefore, interest in alternative agents has led to evaluation of medications such as selepressin, a selective vasopressin V1a receptor agonist.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect